US EditionFake Ozempic drugs found in US drug supply, FDA warns
- The FDA issued a warning about counterfeit Ozempic being sold to consumers.
- Novo Nordisk alerted the FDA on April 3 about counterfeit Ozempic in the U.S. Supply chain.
- The FDA seized several hundred units of fake Ozempic on April 9 labeled with lot PAR0362 and serial numbers starting with 51746517.
- The FDA warns against using products with lot PAR0362 and serial numbers starting with 51746517, as these products may not be safe.
- The FDA and Novo Nordisk are currently testing the seized products to determine their safety, quality and identity.
Insights by Ground AI
Does this summary seem wrong?
31 Articles
31 Articles
All
Left
7
Center
13
Right
4
New York Post+2 Reposted by 2 other sources
Fake Ozempic drugs found in US drug supply, FDA warns
As counterfeit Ozempic circulates in the US, the Food and Drug Administration has issued a warning to Americans.
·New York, United States
Read Full Article
The FDA warns patients about counterfeit Ozempic that may be in circulation
The agency and Novo Nordisk, which makes Ozempic, said Monday that they had learned about "several hundred units" of the drug that made it onto the market outside the company's approved supply chain.
·Washington, United States
Read Full Article
Coverage Details
Total News Sources31
Leaning Left7Leaning Right4Center13Last UpdatedBias Distribution54% Center
Bias Distribution
- 54% of the sources are Center
54% Center
L 29%
C 54%
R 17%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
